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Abstract
Background To evaluate the haemodynamic changes in-
duced by flow diversion treatment in cerebral aneurysms,
resulting in thrombosis or persisting aneurysm patency over
time.
Method Eight patients with aneurysms at the para-
ophthalmic segment of the internal carotid artery were trea-
ted by flow diversion only. The clinical follow-up ranged
between 6 days and 12 months. Computational fluid dynam-
ics (CFD) analysis of pre- and post-treatment conditions was
performed in all cases. True geometric models of the flow
diverter were created and placed over the neck of the aneur-
ysms by using a virtual stent-deployment technique, and the
device was simulated as a true physical barrier. Pre- and
post-treatment haemodynamics were compared, including
mean and maximal velocities, wall-shear stress (WSS) and
intra-aneurysmal flow patterns. The CFD study results were
then correlated to angiographic follow-up studies.
Results Mean intra-aneurysmal flow velocities and WSS
were significantly reduced in all aneurysms. Changes in
flow patterns were recorded in only one case. Seven of eight
aneurysms showed complete occlusion during the follow-
up. One aneurysm remaining patent after 1 year showed no
change in flow patterns. One aneurysm rupturing 5 days
after treatment showed also no change in flow pattern, and
no change in the maximal inflow velocity.
Conclusions Relative flow velocity and WSS reduction in
and of itself may result in aneurysm thrombosis in the
majority of cases. Flow reductions under aneurysm–specific
thresholds may, however, be the reason why some
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aneurysms remain completely or partially patent after flow
diversion.
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stress . Thrombosis
Introduction
Flow diversion technology has already shown great
promise in therapeutic success and outcomes, especially
in the treatment of aneurysms considered otherwise dif-
ficult or by parent vessel reconstruction not possible to
treat [3, 9, 13]. The theoretical background for this
technology relies on the fact that these devices induce
changes in intra-aneurysmal haemodynamics, which re-
sult in progressive thrombosis, occlusion, reverse
remodelling and healing of the parent vessel and aneu-
rysm. But since the location, morphology and size of
aneurysms are all different, the induced haemodynamic
effect is also expected to alter in each case.
The use of flow diverters (FDs) very seldomly pro-
vides immediate thrombosis and occlusion of the aneu-
rysm. With modification of intra-aneurysmal flow, and
with patients under antiplatelet therapy, the healing pro-
cess usually takes time, from days to months. Persisting
patency also became well known to practitioners. Most
importantly, it is still unknown how much flow reduc-
tion is needed to induce progressive aneurysm thrombo-
sis, without leaving an aneurysm unprotected for a
longer time or even exposing it to an increased risk of
rupture. To date there are no reliable measures to pre-
dict the dynamics of aneurysm thrombosis. According to
this, the use of flow diverters in clinical practice still
differs from centre to centre. One of the major differ-
ences relies on the number of overlapping layers used
for the treatment of a single aneurysm. In some centres,
when possible only a single device is used, with the
hope that, irrelevant to the angiographically detectable
intra-aneurysmal flow changes, thrombosis will occur
over time. In other centres, more overlapping layers
are deployed until a subjectively “acceptable” slow
down of flow and stagnation of contrast material is
appreciated.
Our purpose was hence to understand the haemodynamic
changes induced in the aneurysms by a single layer flow
diverter, and to correlate this with clinical follow-up data, in
order to understand which haemodynamic parameter
changes are needed to induce aneurysm occlusion. To re-
produce the changes in haemodynamic conditions due to the
FD, we performed flow simulations in a 3D model of the
diseased vessel.
Materials and methods
Eight patients were retrospectively selected for this study.
The most important selection criterion was para-ophthalmic
location, as this is the most frequent location for FD treat-
ment in the clinical practice. Having all aneurysms from the
same location, the differences due to anatomical location-
related haemodynamics were hence reduced. For consisten-
cy purposes, only patients treated with the same brand of FD
device, the Silk (Balt International, Montmorency, France),
were included in this analysis. Choosing flow diversion as
treatment modality was decided on an individual basis,
taking into consideration the achievable short- and long-
term outcome results with conventional reconstructive endo-
vascular methods (coiling alone or balloon or stent-assisted
coiling). The FD device was in all cases placed in only one
layer, without additional use of coils or other embolic ma-
terial. Patients were prepared with aspirin and clopidogrel
prior to procedure, and the double antiplatelet regime was
continued for 2–3 months post-procedure, whereas aspirin
was continued during the whole follow-up period. A three-
dimensional rotational angiography (3DRA) was obtained
in all patients prior to FD implantation. From this 3D dataset
the concerned vascular segment was extracted and used for
computational flow dynamics analysis. A database contain-
ing patients’ demographics, aneurysm location, dome and
neck size and aspect ratio (AR), and aneurysm flow charac-
teristics, as evaluated by the computerised flow dynamic
analysis, before and after FD implantation (mean and max-
imal intra-aneurysmal flow velocity, mean and maximal
intra-aneurysmal wall-shear stress (WSS), intra-aneurysmal
flow patterns) was created.
The patients were followed for 6–12 months; the aneu-
rysm occlusion status was verified by digital subtraction
angiography (DSA), by CT angiography (CTA) or MR
angiography (MRA).
Vascular and stent models
We reproduced the geometric domain and the position of the
FD to perform flow simulation with and without the device.
We constructed a virtual model of the FD, resembling the
geometry of the actual Silk device—a braided stent com-
posed of 48 wires, 40 wires having a diameter of 30 μm and
eight having a diameter of 50 μm. According to calcula-
tions, the porosity and pore density of an unconstrained
device are 61 % and 21 pores/mm2 respectively. Rhinoceros
4.0 (Seattle, WA, USA) software was used to place the
virtual stent inside the vessel model by bending and fitting
the geometrical stent model to the aneurysm neck and parent
artery wall. The porosity of the deformed stent was used in
the simulations. To reduce computational efforts only the
stent struts at the aneurismal neck were regarded, whereas
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the struts lodged against the artery wall in other areas were
excluded from the model.
After segmentation, the meshing of the domain was per-
formed with ICEM CFD 11.0 (Ansys, Canonsburg, PA,
USA). As the dimensions of the FD struts are small com-
pared with the vessel dimension, we preferred an adaptive
mesh approach. Mesh smoothing was applied using Ansys
inherent smoothing routines. Blood flow was simulated
using Fluent 6.0 (Ansys, Canonsburg, PA, 15317) software.
Blood was regarded as an incompressible Newtonian fluid
with a density of 1.06 g/cm3 and a viscosity of 4 mPa·s. A
fully developed flow, as characterised by the Womersley
solution, was imposed as boundary condition at the inflow
plane. The vessel wall is assumed to be rigid with no slip
boundary condition, the outlets were set to a zero pressure
condition.
As patient-specific blood flow measurements were not
available for the patients analyzed, we set flow rate profiles
using a generic one-dimensional (1-D) physiological model
[11]. The pulse follows a flow rate between 2.1 ml/s and
11.1 ml/s (average flow 4.8 ml/s over full cardiac cycle)
with a velocity between 15.9 cm/s and 84.1 cm/s (average
velocity 36.4 cm/s over full cardiac cycle). This results in a
Reynolds number of between 173 and 914 (average 396),
where the flow is mainly laminar. The Womersley number
of 2.6 characterises a transitional regime with both inertial
effect and viscous effect. The transient flow situation was
computed with a time step of 0.01 s for a cardiac cycle
period of T00.8 s. In each simulation, three cardiac cycles
were computed and only the last cardiac cycle was consid-
ered for the analysis.
Definition of shear-driven and inertia-driven flow The ex-
change of blood between the aneurysm and the parent artery
and the energy deposition depend on the flow conditions.
For shear-driven flow, the aneurysm flow is created by
friction from the parent artery flow. The flow energy into
the aneurysm is low and a low exchange of blood between
the parent artery and the aneurysm cavity is observed. For
inertia-driven flow, the parent artery flow points directly
into the aneurysm. The flow hits the aneurysm dome direct-
ly, creating intense fluidic exchange between the parent
artery and the aneurysm.
Results
Aneurysm characteristics and treatment details
The mean age of the patients was 53±10 years, and there
was only one male. All aneurysms were previously unrup-
tured. The mean of the maximal aneurysm diameter was
10 mm, with a range of 5.5–21.5 mm, and the mean neck
size was 4.5 mm (range, 3–6 mm). The mean AR value was
2.2 (range, 0.9–4.5). Four aneurysms were regular in shape,
and of four irregular shaped aneurysms, two presented with
small blebs on the surface.
All aneurysms were treated with one Silk FD device only.
One patient experienced a delayed rupture of the aneurysm
5 days after treatment, causing her death. One patient
stopped clopidogrel 4 weeks after treatment, resulting in
embolic occlusion of the central retinal artery. This para-
ophthalmic aneurysm was at this time completely throm-
bosed. No further post-procedural complications occurred.
The results are summarised in Table 1.
Occlusion rates after treatment
The follow-up imaging of patients was performed at differ-
ent intervals. Image documentation of aneurysm occlusion
was obtained within a range from 1 to 10 months. One of the
aneurysms showed complete patency and unchanged mor-
phology at 12 months follow-up, with the patient reduced to
single antiplatelet therapy with aspirin only after 3 months
of FD implantation. The aneurysm rupturing at 5 days
showed near to complete thrombosis, with the patient being
under double antiplatelet therapy.
Intra-aneurysmal haemodynamics before and after FD
placement
In the unstented state, the computational fluid dynamics
(CFD) simulations of the aneurysms have shown an inertia
driven flow in three of the eight cases, and a shear-driven
flow in five aneurysms. All aneurysms showed one intra-
aneurysmal vortex, except for an aneurysm with two lobes,
where one vortex was present in each lobe. The change in
flow is characterised as a relative change in velocity and
wall shear stress. The FD induced important reduction of
mean intra-aneurysmal flow velocities (44 % reduction,
12.3±5.3 cm/s pre-stent vs 6.9±4.2 cm/s post-stent for the
mean inflow velocities). The maximal inflow velocity was
slightly less, but still highly reduced (29 % reduction, 69.1±
16 cm/s vs 50±24 cm/s). The mean and maximal intra-
aneurysmal WSS was also significantly reduced (59 % re-
duction, 2.9±1.8 Pa vs 1.3±1.1 Pa; and 58 % reduction,
70.6±68.8 Pa vs 28±31 Pa, respectively).
By dividing aneurysms according to size into two groups
with a cutoff value of 10 mm (two aneurysms >10 mm, six
aneurysms <10 mm), the mean and maximal intra-
aneurysmal flow velocities were remarkably different between
the two groups, both before and after FD placement (mean
velocity before/after FD: 6 cm/s/3 cm/s for the >10 mm
aneurysms vs 14.5 cm/s/8 cm/s for the <10 mm aneur-
ysms), although the rate of change was very similar
(45 % vs 42 %). Same applied for the mean WSS
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(1 Pa/0.2 Pa vs 3.6 Pa/1.6 Pa respectively). The large
aneurysms showed therefore a much slower intra-
aneurysmal flow and lower WSS.
Flow pattern changes
From the eight aneurysms, only one showed an assessable
change in flow pattern, in terms of changed inflow profiles
and flow streamlines (Fig. 1). In the other seven aneurysms,
the intra-aneurysmal flow streamlines did not change after
the placement of the FD, showing only reductions of the
flow velocity and of the WSS. The aneurysm with changed
flow patterns presented originally a shear driven flow, and
showed complete occlusion during the follow-up.
Aneurysm with delayed rupture after treatment
The irregular shaped, 21.5-mm maximal diameter aneu-
rysm (case no. 6) had an aspect ratio (AR) of 3.6. The
aneurysm presented an inertia-driven flow, with a very
high maximal inflow velocity of 97 cm/s, and with very
low mean intra-aneurysmal flow velocities of 5 cm/s.
The maximal WSS corresponding to the inflow zone
area was also extremely high, 121 Pa, as assessed by
CFD simulation. In this case, the FD showed no effect
on the intra-aneurysmal flow pattern. The maximal in-
flow velocity did not change after FD placement, and
the maximal WSS at the level of the inflow area
showed also only a 20 % decrease and persisted at the
barely high level of 97 Pa. Post-treatment, the mean
intra-aneurysmal WSS was highly reduced (with
44 %). Five days after FD placement the aneurysm
ruptured, causing a massive subarachnoid haemorrhage.
Both antiplatelet agents were stopped at this moment. A
CTA performed 1 day later demonstrated complete
occlusion of the aneurysm. There was one similar size
(dome size, 20 mm; AR, 4.5) and morphology aneu-
rysm (case no. 4) in the database. In this case both the
maximal inflow velocity and mean intra-aneurysmal ve-
locity were highly reduced after FD placement (with
49 % and 72 % respectively), accompanied by an im-
portant reduction in the mean WSS (73 %). At the
follow-up after 8 months, this aneurysm was completely
thrombosed.
Aneurysm remaining patent after 1 year of treatment
This regular, broad based, 5.5-mm aneurysm (case no. 8),
with an AR of 1.3 showed complete patency after 1 year,
despite cessation of clopidogrel treatment 9 months before
the last follow-up DSA. The aneurysm presented a shear-
driven flow. The maximal and mean flow velocities were
importantly reduced by the FD (74 to 39 cm/s, 47 % reduc-
tion, and 20 vs 8 cm/s, 60 % reduction respectively). The
maximal and mean intra-aneurysmal WSS also showed ma-
jor reduction after treatment (41 vs 16 Pa, 60 % reduction,
and 4.3 vs 1.4 Pa, 68 % reduction respectively). In this case
the FD showed no effect on the intra-aneurysmal flow
patterns (Fig. 2). There was one aneurysm with similar size
and location in the database (5.6 mm dome size; AR, 1.1),
but with slightly different morphology. The reductions in
maximal and mean flow velocities were less important in
this case compared with the previous one (77 to 67 cm/s,
13 % reduction, and 16 to 13 cm/s, 19 % reduction respec-
tively). The WSS reductions were similar (mean WSS 6.1 to
3.4 Pa, 44 % reduction), although the resulting WSS after
FD placement was in magnitude 2.4-times higher in the non-
occluded aneurysm. Concerning flow pattern changes, this
aneurysm showed an assessable difference in flow pattern
before and after treatment.
Table 1 Patient and aneurysm characteristics
Flow changes
Aneurysm Mean/max velocity (m/s) Mean/max WSS (Pa)
No. Age Gender Location Maximal diameter
(mm)
AR Without FD With FD Change
(%)
Without
FD
With
FD
Change
(%)
Outcome
1 57 F R ICA 5.8 1.1 0.16/0.77 0.13/0.67 19/13 6.05/166 3.4/43 44/74 Occlusion
2 55 F L ICA 6.1 2.0 0.07/0.38 0.04/0.27 39/29 1.2/13 0.6/5.3 50/59 Occlusion
3 59 F R ICA 7.2 1.3 0.13/0.7 0.12/0.62 10/12 4.1/167 2.2/34 46/80 Occlusion
4 71 F L ICA 20.3 4.5 0.07/0.63 0.02/0.32 72/49 0.79/16 0.2/5 73/69 Occlusion
5 54 F R ICA 8.3 2.0 0.16/0.65 0.09/0.45 45/28 2.57/21 1.3/15 48/32 Occlusion
6 45 F R ICA 21.5 3.6 0.05/00.97 0.04/0.97 20/0 1.24/121 0.5/97 60/20 Rupture
7 37 M R ICA 6.1 0.9 0.15/0.69 0.03/0.29 80/58 3.28/20 0.6/5.5 81/72 Occlusion
8 45 F L ICA 5.6 1.3 0.2/0.74 0.08/0.39 60/47 4.36/41 1.4/16 68/60 Persisting patency
1830 Acta Neurochir (2012) 154:1827–1834
Discussion
In this series of para-ophthalmic, originally non-ruptured
aneurysms of the internal carotid artery treated by a single-
layer, braided, low-porosity, high-pore-density FD device,
the effect of flow diversion on intra-aneurysmal flow was
analysed and correlated with clinical outcome in terms of
aneurysm occlusion. The FD induced an important reduc-
tion of the intra-aneurysmal flow velocities and the WSS in
general, independent of aneurysm size. The flow pattern
was changed in only one of eight aneurysms. Six of eight
aneurysms showed a complete occlusion during the follow-
up, while one aneurysm ruptured 5 days after treatment, and
one aneurysm remained still unchanged at 1 year after
device implantation. Having included only aneurysms at
Fig. 1 Irregular para-ophthalmic aneurysm of the right ICA, with the
ophthalmic artery arising from the aneurysm sac, DSA lateral view (a)
and 3DRA reconstruction (b). CFD simulation of flow streamlines
demonstrates an important change of flow pattern besides flow velocity
reduction [before (c) and after FD placement (d)]. Time-of-flight
(TOF) MRA 24 h after treatment demonstrating full patency of the
aneurysm (e), and resorption (completed reverse remodelling) at the
9 months’ follow-up (f)
Fig. 2 Para-ophthalmic aneurysm of the left ICA, with the ophthalmic
artery arising from the neck of the aneurysm, DSA lateral view (a) and
3DRA reconstruction (b). CFD simulation of flow streamlines before
(c) and after (d), and WSS distribution before (e) and after (f) virtual
placement of the FD over the aneurysm neck. Although the flow
velocities and the WSS are considerably reduced, the flow pattern
remained unchanged. The aneurysm remained patent 1 year after
treatment, as shown by the lateral view DSA of the left ICA (g)
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para-ophthalmic location, these results may not apply to
aneurysms at other points of the circle of Willis.
FDs provided a very important endovascular tool for the
reconstructive treatment of difficult and high recurrence rate
aneurysms. Pre-clinical and clinical series have shown that
these devices induce thrombosis of the aneurysm, followed
by sealing of the luminal surface by a layer of neointimal
tissue, which will consequently lead to cicatrisation and
reverse remodelling of the aneurysm. The process of pro-
gressive thrombosis and aneurysm occlusion probably
depends on several factors, but most importantly on the
induced intra-aneurysmal flow changes. This is related to
the size, location and morphological characteristics of the
aneurysm, the number of FDs deployed over the neck (more
layers may have a more pronounced flow diverting effect)
and the deployment technique, which may have major in-
fluence on the FD porosity. On the other hand, the aneurysm
thrombosis is probably also related to the ongoing antipla-
telet therapy and the patient’s personal haemostatic profile,
although the impact of antiplatelet therapies on intra-
aneurysmal clot development is barely known. The process
is seldom predictable, which may raise two major concerns.
First, certain aneurysms treated with flow diversion alone
seem to be not protected from rupture during the phase of
thrombosis [8]. Second, some aneurysms remain patent and
show no or only partial thrombosis during months or even
years after treatment [3, 7, 9, 10, 13]. This may cause
uncertainty for both the physician and patient, and on the
other hand limit the re-treatment options (no more intra-
saccular access through the device possible due to the high
mesh density of the device).
In this series, the Silk FD device was simulated based on
its real geometrical properties as true physical barrier over
the neck of the aneurysm, as previously described [2]. In
accordance with published small case studies [2, 4], our
results have shown that the most important effect of the
device is measurable in the relative reduction of intra-
aneurysmal flow velocities and WSS. The maximal inflow
velocities were less reduced than the mean intra-aneurysmal
flow velocities in general. The device showed a more im-
portant effect on reduction of mean and maximal intra-
aneurysmal WSS. Both these results suggest a real slow-
down of intra-aneurysmal flow and an increased intra-
aneurysmal flow residence time compared with pre-
treatment status. The results are in concordance with the
animal studies [12] and clinical experience, showing that
FDs increase the contrast material washout time of the
aneurysm. It is well known that slow flow and consequent
low WSS are important factors for inducing thrombosis [1],
which correlates with the clinical effect of flow diversion.
It is important to note that, as expected, large aneurysms
showed a slower intra-aneurysmal flow and lower WSS than
the small (<10 mm) ones. The mean flow velocities and the
mean WSS after FD treatment in the small group were still
higher than in the large group before treatment. Although
the low number of cases does not allow for a real compar-
ison, this strongly suggests that the induced relative change
in the intra-aneurysmal flow profile will lead the process of
thrombosis, and not the fair value of velocity and WSS. All
aneurysms may therefore present specific threshold values
of flow and WSS, where progressive thrombosis will be
initiated.
By analysing the flow dynamics of the aneurysm with
delayed rupture, the most important difference in compari-
son with the others was the aneurysm size and morphology,
of and the lack of reduction of the maximal inflow velocity.
This was the largest aneurysm from the series with a max-
imal diameter of 21.5 mm, with an AR of 3.6. Both these
parameters were already indirectly suggestive of aneurysm
wall vulnerability and of an elevated risk of rupture [14, 15].
Probably due to the further reduction, an already very slow
mean flow velocity and WSS, the aneurysm demonstrated a
quick thrombosis after treatment. Due to the quickly devel-
oped large clot volume, the aneurysm wall might be exposed
to thrombus-induced autolytic activities and may be over-
whelmed by the large destructive enzymatic overload, lead-
ing to structural destruction of the aneurysm wall, as
previously described [5, 6, 8]. On the other hand, the max-
imal and otherwise very high inflow velocity was practically
unchanged by the FD device, as measured by CFD, and the
intra-aneurysmal flow patterns and the inflow zone also
remained unchanged. We may hence hypothesise that the
thrombus could not conquer this territory due to the persist-
ing very high flow velocity in this region. This persisting
inflow jet could then act as a dissector in between the
already formed destructive thrombus and the destroyed an-
eurysm wall, causing the devastating rupture. The major
difference between this aneurysm and the one with similar
size, location and morphology was the lack of reduction in
intra-aneurysmal flow velocities, which may explain the
devastating effect of a persisting high energy inflow jet.
In the 5-mm aneurysm demonstrating persistent patency
during 12 months after treatment, mean and maximal veloc-
ities as well as WSS were all significantly reduced accord-
ing to the simulations; however, the flow pattern remained
the same (Fig. 2). We hypothesise that with an unchanged,
regular, single-vortex flow pattern, the induced velocity and
WSS reductions probably still did not reach the threshold of
thrombosis at this aneurysm size, keeping the aneurysm
patent. In a similar size and shape aneurysm with a similar
AR (case no. 1), despite less important reduction rates in
intra-aneurysmal velocity and WSS, this aneurysm showed
complete occlusion and reverse remodelling during the fol-
low up. Besides probable individual differences in the hae-
modynamic conditions, the major difference between the
two cases was that in the case with thrombosis the FD
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induced a significant change in the intra-aneurysmal flow
patterns, which may be an explanation for its thrombosis.
Interestingly, the FD induced a significant change in flow
pattern only in one of the eight aneurysms. In this case,
besides a significant reduction in flow velocities and WSS,
the streamlines of the flow were also dramatically changed,
with disappearance of the jet type inflow (Fig. 1). If we
consider the term “diversion”, with the meaning of an in-
stance of turning something aside from its natural course,
the real flow diversion effect was achieved only in this case,
while in the vast majority of the aneurysms at this location,
only a magnitude reduction of the flow energy was induced
by the device. In five of these seven aneurysms, this reduc-
tion was enough to induce thrombosis and complete occlu-
sion. Despite significant velocity and WSS reductions, one
aneurysm remained patent for 12 months after treatment.
Another aneurysm, where the FD did not modify the very
strong inflow jet, ruptured 5 days after treatment. These
facts may suggest that, in certain cases, modification of flow
patterns or, more importantly, reductions of velocity and
WSS may be necessary. This could be achieved by applying
multiple overlapping FD layers or by intra-saccular aneu-
rysm coiling.
The limitations of the study are related to: the low num-
ber of cases analysed; the difference in size and morpholog-
ical characteristics of the involved aneurysms; the lack of
patient specific flow profile data, with all cases having
applied the same flow profile; the idealised deployment of
the FD device in the CFD simulations, which may not
always be the case in the clinical setting; the lack of high
frame rate angiographic imaging before and after FD de-
ployment to be correlated with the CFD simulations for
validation reasons. With the new angiographic devices this
option is becoming more widely available in the near future.
The power of this study does not yet allow us to predict
how many FD layers would suffice to induce controlled
thrombosis and reverse remodelling of a specific aneurysm.
We believe, however, that CFD simulations may now be
more regularly applied prior to treatment in all elective cases
and, by gathering more data with clinical correlation, may
become an additional tool in treatment planning.
Conclusions
In this series of para-ophthalmic aneurysms treated by flow
diversion obtained by endovascular deployment of a single-
layer, braided, low-porosity, high-pore-density FD device,
we correlated clinical occlusion rates with retrospective
CFD assessments. We found main flow modification to
consist in mean intra-aneurismal blood flow velocity and
WSS reductions. These changes may be enough to induce
complete thrombosis and subsequent aneurysm reverse
remodelling as clinically observed in the majority of the
studied cases; however, exact threshold values of flow re-
duction could not be determined, since all aneurysms have
their characteristic flow profile. Modification of the flow
pattern was observed in only one of eight cases and we
therefore cannot comment on a possible predictive role of
this parameter. Further, as observed, a single-layer FD may
not be able to break a very strong inflow jet at the aneurysm
entry point but still reduce the mean intra-aneurysmal flow,
and by this fail to clot at all or induce partial thrombosis
only. Such thrombosis may have a destructive effect on the
aneurysm wall, which—in combination with a persisting
inflow jet—may cause the aneurysm to rupture with delay.
We believe that these mechanisms could explain retrospec-
tively the two treatment failures observed in the cases eval-
uated. Numerical simulation may possibly help to predict
such failures and, if proven by larger series, become a tool to
provide a safer treatment to our patients.
Finally, in lack of flow pattern changes one might chal-
lenge the currently common used term of “flow diverter” for
this type of vascular repair devices.
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